Detalhe da pesquisa
1.
Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment.
Lancet Oncol
; 22(10): e430-e434, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592192
2.
Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France.
Mult Scler
; 26(1): 118-122, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30541380
3.
Biallelic MYORG mutation carriers exhibit primary brain calcification with a distinct phenotype.
Brain
; 142(6): 1573-1586, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31009047
4.
Late-onset neutropenia and neurological relapse, during long-term rituximab therapy in myelin oligodendrocyte glycoprotein-antibody spectrum disorder.
Mult Scler
; 24(12): 1645-1647, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29741120
5.
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.
Mult Scler
; 24(2): 96-120, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29353550
6.
Assessment of a program to encourage the multidisciplinary management of urinary disorders in multiple sclerosis.
Neurourol Urodyn
; 36(3): 706-709, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27028504
7.
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.
Mult Scler
; 22(13): 1719-1731, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27589059
8.
Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.
Brain
; 138(Pt 2): 284-92, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25527826
9.
Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients.
Neurourol Urodyn
; 34(1): 32-6, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24115110
10.
Risk evaluation and monitoring in multiple sclerosis therapeutics.
Mult Scler
; 20(10): 1306-11, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24293456
11.
Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.
Brain
; 135(Pt 10): 2980-93, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23065789
12.
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
Ann Neurol
; 69(2): 292-302, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21387374
13.
Increased risk of multiple sclerosis relapse after in vitro fertilisation.
J Neurol Neurosurg Psychiatry
; 83(8): 796-802, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22693287
14.
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.
Brain
; 134(Pt 3): 693-703, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21354972
15.
Association of Central Hypersomnia and Fatigue in Patients With Multiple Sclerosis: A Polysomnographic Study.
Neurology
; 97(1): e23-e33, 2021 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33931534
16.
Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial.
Lancet Neurol
; 20(11): 917-929, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687636
17.
Natural history of multiple sclerosis with childhood onset.
N Engl J Med
; 356(25): 2603-13, 2007 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-17582070
18.
Fingolimod treatment after natalizumab-related progressive multifocal leukoencephalopathy: three new cases.
Mult Scler
; 21(5): 671-2, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25305251
19.
Relevance of the skewness index in DTI exploration of multiple sclerosis.
MAGMA
; 22(2): 89-100, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18998181
20.
Cervical dysplasia in a patient with multiple sclerosis treated with natalizumab.
Fundam Clin Pharmacol
; 33(1): 125-126, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29935014